Jefferies cuts Nike stock price target on China, Jordan headwinds

Nike shares fell 9% after fiscal Q1 2027 revenue of $11.21B missed the $11.35B consensus, despite EPS of $0.48 beating the $0.44 forecast. Management projected a high-single-digit full-year revenue decline, with Greater China sales down 26% and continued weakness in Nike Sportswear and Jordan. Gross margin improved to 42.8%, while Performance categories and North America (+2%) showed early turnaround progress; Jefferies nevertheless cut its price target to $60 from $75 while retaining a Buy rating.

Analysis

The key debate is whether category-level momentum can offset a shrinking legacy profit pool before promotional activity reaccelerates. The earnings beat appears cost-led rather than demand-led; without sequential improvement in full-price sell-through, margin stabilization is unlikely to support multiple expansion. A prolonged reset also risks weakening Nike’s shelf-space leverage with wholesale partners, creating an opening for ONON, DECK’s HOKA, and ADDYY to retain premium running and lifestyle allocations through the next buying cycle.

Near term, the stock is vulnerable to another estimate-reset cycle as analysts reconcile a high-single-digit annual sales decline with expectations embedded in a recovery valuation. The most important 1-3 month data points are China sequential sell-through, North American wholesale replenishment, digital traffic/conversion, and inventory days—not another modest EPS beat generated by expense control. Over 6-18 months, the upside case requires evidence that performance-product growth converts into higher-margin franchise demand rather than merely cannibalizing discounted Sportswear and Jordan sales.

Consensus may be too negative on the durability of the performance portfolio, but the market is correctly discounting execution risk: a low absolute share price is not itself a catalyst. A sustainable rerating requires revenue stabilization and reduced markdown dependence; absent that, gross-margin gains could reverse as channel inventory is cleared. The bearish thesis is falsified by two consecutive quarters of positive total constant-currency revenue, a material China sequential recovery, and maintained gross margin despite lower promotional intensity.

Key Decisions for Investors

• Maintain NKE underweight for the next 1-3 months; avoid adding outright long exposure solely on valuation. Reassess after evidence of inventory normalization and a revenue-guide floor, rather than an EPS beat driven by SG&A restraint.
• Initiate a beta-adjusted pair: long ONON / short NKE over a 3-6 month horizon. The trade isolates premium performance-footwear share gains versus Nike’s broader brand-reset risk; target 10-15% relative outperformance, with a stop if NKE closes above $40 or reports broad-based revenue stabilization.
• For downside hedging, use a 3-6 month NKE put spread rather than naked short exposure, given depressed sentiment and the possibility of a sharp relief rally from margin commentary. Size premium at risk to 1-2% of the equity sleeve; take profits if consensus revenue estimates fall materially following the next update.
• Monitor FL, DKS, and JD Sports supplier/category commentary for second-order confirmation. Improving non-Nike running and lifestyle sell-through alongside restrained Nike replenishment would strengthen the relative-short thesis; broad Nike wholesale reorders would invalidate it.